表紙：心臓補綴デバイスの市場規模、シェア、成長分析、製品タイプ別、材料タイプ別、最終用途別、地域別 - 産業予測、2025年～2032年

市場調査レポート

商品コード

1758687

心臓補綴デバイスの市場規模、シェア、成長分析、製品タイプ別、材料タイプ別、最終用途別、地域別 - 産業予測、2025年～2032年

Cardiac Prosthetic Devices Market Size, Share, and Growth Analysis, By Product Type (Heart Valves, Pacemakers), By Material Type (Biological Materials, Synthetic Materials), By End-Use, By Region - Industry Forecast 2025-2032

出版日: 2025年06月18日
発行: SkyQuest
ページ情報: 英文 193 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 766,592円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 896,768円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,026,944円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.64円

全表示
概要
目次

概要

サンプル依頼リストに入れる

心臓補綴デバイスの世界市場規模は2023年に69億3,000万米ドルとなり、予測期間（2025年～2032年）のCAGRは7.8%で、2024年の74億7,000万米ドルから2032年までには136億2,000万米ドルに成長する見通しです。

心臓補綴デバイスの世界市場は、心臓の加齢性変化により心血管疾患のリスクが高まる高齢者人口の急増に大きな影響を受けています。この人口動態の変化により、大動脈弁狭窄症や心不全などの疾患が増加し、人工弁やペースメーカーを利用した外科手術が急増しています。これと並行して、低侵襲経カテーテル大動脈弁置換術（TAVR）、3Dプリンターによる個別化心臓弁、生体適合性材料などの技術進歩が、これらのデバイスの有効性と安全性を高めています。これらの技術革新は手術リスクや回復時間を減少させるだけでなく、長期的な転帰を改善することで、ヘルスケア環境全体における人工心臓の需要を高め、市場の継続的な成長を促進しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022年～2024年）

主要企業プロファイル

Abbott Laboratories（USA）
Medtronic plc（Ireland）
Boston Scientific Corporation（USA）
Edwards Lifesciences Corporation（USA）
LivaNova PLC（UK）
Biotronik（Germany）
MicroPort Scientific Corporation（China）
Meril Life Sciences Pvt. Ltd.（India）
Lepu Medical Technology Co., Ltd.（China）
CryoLife, Inc.（USA）
AtriCure, Inc.（USA）
Braile Biomedica（Brazil）
Labcor Laboratorios Ltda.（Brazil）
Lifetech Scientific Corporation（China）
Shree Pacetronix Ltd.（India）
TTK Healthcare Ltd.（India）
Colibri Heart Valve LLC（USA）
Berlin Heart GmbH（Germany）
SynCardia Systems LLC（USA）
Venus Medtech（Hangzhou）Inc.（China）

結論と提言

Product Code: SQMIG35A3042

Global Cardiac Prosthetic Devices Market size was valued at USD 6.93 billion in 2023 and is poised to grow from USD 7.47 billion in 2024 to USD 13.62 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The global market for cardiac prosthetic devices is significantly influenced by the rapidly growing elderly population, which faces heightened risks of cardiovascular diseases due to age-related changes in the heart. This demographic shift is resulting in increased incidences of conditions like aortic stenosis and heart failure, leading to a surge in surgical procedures that utilize prosthetic valves and pacemakers. In parallel, technological advancements such as minimally invasive transcatheter aortic valve replacement (TAVR), 3D-printed personalized heart valves, and biocompatible materials are enhancing the efficacy and safety of these devices. These innovations not only decrease surgical risks and recovery times but also improve long-term outcomes, thereby elevating the demand for cardiac prosthetics across healthcare settings and fostering continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Prosthetic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Prosthetic Devices Market Segments Analysis

Global Cardiac Prosthetic Devices Market is segmented by Product Type, Material Type, End-Use and region. Based on Product Type, the market is segmented into Heart Valves, Pacemakers and Others. Based on Material Type, the market is segmented into Biological Materials, Synthetic Materials and Hybrid Materials. Based on End-Use, the market is segmented into Hospitals, Cardiac Centers and Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Prosthetic Devices Market

The increasing prevalence of cardiac diseases worldwide is a significant factor propelling the growth of the global cardiac prosthetic devices market. As conditions such as coronary artery disease and heart valve disorders become more common, the demand for prosthetic solutions, including heart valves and vascular grafts, escalates. This rising need not only highlights the urgency for effective treatment options but also paves the way for advancements and innovations within the market. Consequently, this trend creates substantial opportunities for manufacturers and healthcare providers to develop and deliver advanced cardiac prosthetic devices, thereby enhancing patient outcomes and market expansion.

Restraints in the Global Cardiac Prosthetic Devices Market

The Global Cardiac Prosthetic Devices market faces significant challenges due to lengthy and complex regulatory approval processes. The rigorous regulatory demands, along with the necessity for extensive clinical trials and testing, can significantly delay the market entry of new devices. This prolonged timeline not only stifles innovation but also limits patient access to the latest technological advancements. Consequently, these regulatory hurdles can impede progress in the industry, making it difficult for patients to benefit from newly developed cardiac prosthetic solutions in a timely manner.

Market Trends of the Global Cardiac Prosthetic Devices Market

The global cardiac prosthetic devices market is increasingly trending towards advancements in minimally invasive procedures, reflecting a growing preference for technologies that enhance patient outcomes. Innovative devices such as transcatheter heart valves and catheter-based repair systems are gaining traction, driven by their ability to minimize surgical trauma, reduce recovery times, and lower complication risks. As healthcare providers and patients alike prioritize efficiency and safety, the demand for these sophisticated devices is expected to surge. This shift not only aligns with evolving surgical practices but also fosters competitive growth among manufacturers, leading to ongoing technological advancements within the cardiac prosthetics segment.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Analysis

Global Cardiac Prosthetic Devices Market Size by Product Type & CAGR (2025-2032)

Market Overview
Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves (TAVR)
Pacemakers
- Implantable Pacemakers
- External Pacemakers
Others
- Ventricular Assist Devices (VADs)
- Total Artificial Hearts (TAH)

Global Cardiac Prosthetic Devices Market Size by Material Type & CAGR (2025-2032)

Market Overview
Biological Materials
- Bovine Pericardium
- Porcine Tissue
Synthetic Materials
- Titanium
- Polyurethane
- Carbon
Hybrid Materials

Global Cardiac Prosthetic Devices Market Size by End-Use & CAGR (2025-2032)

Market Overview
Hospitals
Cardiac Centers and Clinics
Ambulatory Surgical Centers
Others

Global Cardiac Prosthetic Devices Market Size & CAGR (2025-2032)

North America (Product Type, Material Type, End-Use)
- US
- Canada
Europe (Product Type, Material Type, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Material Type, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Material Type, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Material Type, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braile Biomedica (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcor Laboratorios Ltda. (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifetech Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TTK Healthcare Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Colibri Heart Valve LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berlin Heart GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynCardia Systems LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Venus Medtech (Hangzhou) Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

心臓補綴デバイスの市場規模、シェア、成長分析、製品タイプ別、材料タイプ別、最終用途別、地域別 - 産業予測、2025年～2032年

Cardiac Prosthetic Devices Market Size, Share, and Growth Analysis, By Product Type (Heart Valves, Pacemakers), By Material Type (Biological Materials, Synthetic Materials), By End-Use, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

心臓補綴デバイスの市場規模：製品タイプ別・CAGR（2025年～2032年）

心臓補綴デバイスの市場規模：材料タイプ別・CAGR（2025年～2032年）

心臓補綴デバイスの市場規模：最終用途別・CAGR（2025年～2032年）

心臓補綴デバイスの市場規模・CAGR（2025年～2032年）